This is the authors' abstract. We don't add key points for this paper.
The efficacy of conventional treatments for previously treated advanced BTC patients is poor and could be improved by novel therapies.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Amonkar et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: